United States · FDA National Drug Code directory
epinephrine
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 0115-1694_fdafd090-bed3-4f16-8ab1-fd1573aa633e
- Product NDC
- 0115-1694
- Form
- INJECTION
- Composition / generic term
- epinephrine
- Labeler
- Amneal Pharmaceuticals of New York LLC
- Marketing category
- NDA AUTHORIZED GENERIC
- Marketing start / end (source format)
- 20100401
- Source listing expiry
- 20271231
Source-listed ingredients
- EPINEPHRINE — .3 mg/.3mL
These values do not establish equivalence or a dose recommendation.
Packages
- 1 CASE in 1 CARTON (0115-1694-30) / 1 SYRINGE, GLASS in 1 CASE / .3 mL in 1 SYRINGE, GLASS · 0115-1694-30
- 2 CASE in 1 CARTON (0115-1694-49) / 1 SYRINGE, GLASS in 1 CASE / .3 mL in 1 SYRINGE, GLASS · 0115-1694-49
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →